Lobectomy versus stereotactic body radiotherapy for stage i non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 3, 2015, Pages 468-471

  Meyers, Bryan F ^a   Puri, Varun ^a   Broderick, Stephen R ^a   Samson, Pamela ^a   Keogan, Kathleen ^a   Crabtree, Traves D ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DISEASE SEVERITY; DISTANT METASTASIS; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LYMPH NODE METASTASIS; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT MONITORING; PATIENT SAFETY; POST HOC ANALYSIS; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; TUMOR VOLUME; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; MALE; RADIOSURGERY; TEMPORAL LOBECTOMY; TUMOR RECURRENCE;

ANTERIOR TEMPORAL LOBECTOMY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 84940451133     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.06.086     Document Type: Editorial

References (11)

1. J.Y. Chang, S. Senan, M.A. Paul, R.J. Mehran, A.V. Louie, P. Blater, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials Lancet Oncol 16 2015 630 637
2. T. Treasure, R.C. Rintoul, and F. Macbeth SABR in early operable lung cancer: time for evidence Lancet Oncol 16 2015 597 598
3. H.C. Fernando, and R. Timmerman American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer J Thorac Cardiovasc Surg 144 2012 S35 S38
4. Randomized Study to Compare CyperKnife to Surgical Resection in Stage I Non-Small Cell Lung Cancer (STARS). Available at: https://clinicaltrials.gov/archive/NCT00840749/2009-02-09. Accessed June 2015.
5. Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer (ROSEL). Available at: https://clinicaltrials.gov/ct2/show/NCT00687986. Accessed June 2015.
6. S.S. Ellenberg, T.R. Fleming, and D.L. DeMets Statistical, Philosophical and Ethical Issues In Data Monitoring Committees in Clinical Trials: A Practical Perspective 2002 John Wiley & Sons Ltd Hoboken, NJ
7. C. Fernando, R.J. Landreneau, S.J. Mandrekar, S.L. Hillman, F.C. Nichols, B. Meyers, and et al. Thirty and ninety day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study J Thorac Cardiovasc Surg 142 2011 1143 1151
8. V. Puri, T.D. Crabtree, J.M. Bell, D. Kreisel, A.S. Krupnick, S. Broderick, and et al. National Cooperative Group trials of "high-risk" patients with lung cancer: are they truly "high-risk"? Ann Thorac Surg 97 2014 1678 1685
9. B.D. Kozower, S. Sheng, S.M. O'Brien, M.J. Liptay, C.L. Lau, D.R. Jones, and et al. STS database risk models: predictors of mortality and major morbidity for lung cancer resection Ann Thorac Surg 90 2010 875 881
10. B.K. Stiles, E.L. Servais, P.C. Lee, J.L. Port, S. Paul, and N.K. Altorki Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging J Thorac Cardiovasc Surg 137 2009 13 19
11. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer (STABLE-MATES). Available at: https://www.clinicaltrials.gov/ct2/show/NCT02468024. Accessed June 15, 2015.